Department of Medicine/Rheumatology, MetroHealth Medical Center/Case Western Reserve University, Cleveland, Ohio 44109, USA.
Ann Rheum Dis. 2012 Jun;71(6):1073-80. doi: 10.1136/annrheumdis-2011-200519. Epub 2012 Jan 31.
Cyclooxygenase-2 (COX-2) expression is associated with the pathogenesis of chronic inflammation and pain in osteoarthritis (OA). A study was undertaken to determine whether interleukin-1β (IL-1β)-mediated induction of COX-2 can be regulated by microRNAs (miRNAs) in OA.
Human chondrocytes were stimulated with IL-1β in vitro. Total RNA was prepared using Trizol reagent. Gene expression was quantified using TaqMan Assays and miRNA targets were identified using bioinformatics. Transfection with reporter construct and premiRNA and antimiRNA was employed to verify suppression of target mRNA. Expression of COX-2 proteins was determined by immunoblotting. The role of activated p38-MAPKs was evaluated using specific inhibitor.
The 3'UTR of COX-2 mRNA contained the 'seed-matched' sequences for miR-199a* and miR-101_3. Increased expression of COX-2 correlated with the downregulation of miR-199a* and miR-101_3 in IL-1β-stimulated normal and OA chondrocytes. miR-199a* directly suppressed the luciferase activity of a COX-2 3'UTR reporter construct and inhibited the IL-1β-induced expression of COX-2 protein in OA chondrocytes. Modulation of miR-199a* expression also caused significant inhibition of IL-1β-induced upregulation of mPGES1 and prostaglandin E(2) production in OA chondrocytes. Activation of p38-MAPK downregulated the expression of miR-199a* and induced COX-2 expression. Treatment with antimiR-101_3 increased COX-2 expression in IL-1β-stimulated chondrocytes, but overexpression of miR-101_3 had no significant effect on COX-2 protein expression.
miR-199a* is a direct regulator of COX-2 expression in OA chondrocytes. IL-1β-induced activation of p38-MAPK correlates inversely with miR199a* expression levels. miR-199a* may be an important regulator of human cartilage homeostasis and a new target for OA therapy.
环氧化酶-2(COX-2)的表达与骨关节炎(OA)慢性炎症和疼痛的发病机制有关。本研究旨在确定白细胞介素-1β(IL-1β)介导的 COX-2诱导是否可以在 OA 中通过 microRNAs(miRNAs)进行调节。
在体外用人软骨细胞刺激 IL-1β。使用 Trizol 试剂提取总 RNA。使用 TaqMan 测定法定量基因表达,并使用生物信息学鉴定 miRNA 靶标。使用报告构建体和 premiRNA 和 antimiRNA 转染来验证靶 mRNA 的抑制。通过免疫印迹测定 COX-2 蛋白的表达。使用特定抑制剂评估激活的 p38-MAPKs 的作用。
COX-2 mRNA 的 3'UTR 包含 miR-199a和 miR-101_3 的“种子匹配”序列。在 IL-1β刺激的正常和 OA 软骨细胞中,COX-2 的表达增加与 miR-199a和 miR-101_3 的下调相关。miR-199a直接抑制 COX-2 3'UTR 报告构建体的荧光素酶活性,并抑制 OA 软骨细胞中 IL-1β诱导的 COX-2 蛋白表达。miR-199a表达的调节也导致 IL-1β诱导的 mPGES1 和前列腺素 E(2)产生在 OA 软骨细胞中的显著抑制。p38-MAPK 的激活下调 miR-199a*的表达并诱导 COX-2 表达。用 antimiR-101_3 处理可增加 IL-1β刺激的软骨细胞中 COX-2 的表达,但 miR-101_3 的过表达对 COX-2 蛋白表达没有显著影响。
miR-199a是 OA 软骨细胞中 COX-2 表达的直接调节剂。IL-1β诱导的 p38-MAPK 激活与 miR199a表达水平呈负相关。miR-199a*可能是人类软骨稳态的重要调节剂,也是 OA 治疗的新靶点。